{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-24-041796","form_type":"8-K","ticker":"DARE","cik":"0001401914","company_name":"Dare Bioscience, Inc.","filed_at":"2024-10-21T23:59:59+00:00","discovered_at":"2026-05-14T18:03:08.349394+00:00","generated_at":"2026-05-30T12:19:03.285222+00:00","sec_items":["1.01","3.02","7.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Daré Bioscience secures $15M common stock purchase facility with Lincoln Park Capital","bullets":["Entered $15M common stock purchase agreement with Lincoln Park Capital Fund, LLC.","Daré has sole discretion to sell up to $15M shares over 24 months; LPC obligated to buy at market-based prices.","Proceeds intended to help fund Phase 3 program for Sildenafil Cream, 3.6% (estimated $15M direct costs).","Issued 137,614 commitment shares to LPC; no warrants issued, no short selling permitted.","Daré may terminate agreement at any time with no cost or penalty."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-24-041796","json":"https://secwatch.observer/filing/0001493152-24-041796.json","markdown":"https://secwatch.observer/filing/0001493152-24-041796.md","text":"https://secwatch.observer/filing/0001493152-24-041796.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1401914/000149315224041796/0001493152-24-041796-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1401914/000149315224041796/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-30T12:19:03.285222+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}